Clasado will be attending Probiota Europe 2024, one of the leading industry events dedicated to health and nutrition product formulations in the European market.

Members of the Clasado team, CEO Per Rehne and VP of B2B Sales Dr. Frederic Narbel, will be available to discuss all things prebiotic, including the latest insights, research and product developments into its Bimuno® GOS ingredient.

Click here to contact the Clasado team and arrange a meeting during Probiota Europe 2024.

Per Rehne, CEO at Clasado, said: “As we look ahead to another full calendar of events through 2024, we are eager to open new dialogue with businesses from around the world and share insights into the power of prebiotics. We’re in the age of information, and consumers are getting more proactive with matters of health.

“We’ll be connecting with delegates to show not just why Bimuno GOS is a leading prebiotic choice today, but also how it meets future needs. It is going from strength to strength in health areas such as gastrointestinal and immune health, but also demonstrating capabilities for its use in synbiotics – our collaboration with Probi AB is a prime example. As the scientific understanding of the gut microbiome grows, we’re finding new market potential for prebiotics, which makes it a very exciting prospect in the health and nutrition category.”

Taking place 7-9 February 2024 in Milan, Italy, the event enables health and nutrition businesses, exploring the next generation of functional ingredients, to connect with the latest scientific developments.

Members of the Clasado team will be sharing insight on the most comprehensively studied commercially available prebiotic galactooligosaccharide, Bimuno GOS. Backed by over 110 scientific publications exploring its role in digestive, gastrointestinal, immune, and cognitive health, including more than 20 clinical studies, the ingredient is ideal for meeting the demands of today’s health audience.

Clasado Biosciences invites attendees of Probiota Europe 2024 to arrange a meeting here with its team to discover the capabilities of prebiotics and discuss potential collaborations.